Zacks Investment Research on MSN
OM stock gains on FDA clearance for next-gen Tablo dialysis system
Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, ...
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する